焦作高中复读靠谱的有哪些河南中考补习哪里有哪里好,汉中应届生民办高中哪里好,渭南高考补习靠谱的联系方式,郑州学校实力排名,汉中高考复读哪里有有哪些,长安区高二补习班效果好,濮阳中学补习班实力价格

WASHINGTON — The U.S. government on Tuesday will start distributing 30,000 doses of an experimental monoclonal antibody drug to fight COVID-19, the one President Donald Trump received last month.Over the weekend, the Food and Drug Administration agreed to allow emergency use of the therapeutic, casirivimab and imdevimab, made by Regeneron Pharmaceuticals Inc., for people with mild-to-moderate symptoms who are at high risk of developing serious illness because of their age or other medical conditions.The treatment was not authorized for use in sicker, hospitalized patients or those who need extra oxygen.President Donald Trump was given the therapeutic treatment when he contracted coronavirus in October. The Department of Health and Human Services said the federal government announced funding over the summer to support large-scale manufacturing of casirivimab and imdevimab.The agency will allocate “these government-owned doses to state and territorial health departments which, in turn, will determine which healthcare facilities receive the infusion drug,” reads a statement from HHS.“Beginning immediately, weekly allocations to state and territorial health departments will be proportionally based on confirmed COVID-19 cases in each state and territory over the previous seven days, based on data hospitals and state health departments enter into the HHS Protect data collection platform,” reads the HHS statement.Antibodies bind to the virus and help the immune system eliminate it. The Regeneron drug is a combo of two antibodies that seemed to do this well in lab tests.The emergency use authorization allows limited use of a drug while studies continue to test its safety and effectiveness. Early results suggest it may reduce COVID-19-related hospitalization or emergency room visits.The drugs are given as a one-time treatment through an IV and takes about an hour.Under federal contracts, the drugs for now will be supplied for free, although patients may have to pay part of the cost of the IV treatment. 2036

Voters were polarized after learning of Brett Kavanaugh's confirmation as a Supreme Court Justice.Both Republicans and Democrats who spoke with 10News on camera said they are frustrated with the way Doctor Christine Blasey?Ford's accusations were handled.READ RELATED:Brett Kavanaugh sworn in as Supreme Court justice"I'm truly just disgusted with the outcome and I'm just really disappointed with in our nation and what we stand for today," College Student Ngozi Egeonu said."It's very disappointing, I think it's very hurtful," Republican Ana Assaf said."He didn't give straight answers to me it seemed, then again I didn't see the whole interview, only saw bits and pieces," San Diegan Melvin Zelaya said.Egeonu said she's now concerned about Dr. Ford, "Now I'm worried about her own safety, and her own image knowing that she put herself out there and knowing this is something very traumatic that she's having to recall."They all agreed the FBI investigation felt rushed and inconclusive."I think it was disrespectful to the ladies who accused him and I don't think the whole, they didn't have enough time to investigate," Assaf said."I was surprised that that wasn't enough for them to be like hey, no we shouldn't nominate him," Zelaya said.Some believe the accusations are false and the timing is inappropriate, calling it a smear campaign. Zelaya says the past is relevant, "I think it is important because you know being on the Supreme Court is a really big deal, you're going to be on there the rest of your life and you're going to be making decisions that affect every citizen in this country's life."With the highly publicized hearings, some hope it will bring change."With this experience maybe he'll be open and fair, but I mean if he's already been sworn in there's nothing we can do now," Assaf said."I don't know if it will be enough to make an impact on how he stands as a person, I wish it would but I don't see that being much of a change for him," Egeonu said.Kavanaugh's confirmation tips the court in favor of Conservatives, concerning some voters. Zelaya said it is better to have an even and fair court. He said he was fond of Antonin Scalia because he was the wild card.An issue many women are concerned about is abortion and how Kavanaugh will vote on those cases."We have all these issues that are recycling from the past and I don't feel like anything is getting better, I hope with this people are able to wake up," Egeonu said.Kavanaugh's first cases are next week and focus on immigration, asbestos and firearms. 2639

VISALIA, Calif. (AP) — A California prosecutor has charged a high school teacher with several child cruelty and battery counts after she forcibly cut the hair of one of her students.Tulare County District Attorney Tim Ward said in a news release Friday that 52-year-old Margaret Gieszinger faces up to 3 years and 6 months in jail if convicted of all six counts.Gieszinger was arrested Wednesday after video posted to social media showed a student at University Preparatory High School in Visalia sitting in a chair as she cuts his hair.In a video obtained by KFSN-TV, the science and chemistry teacher is heard belting the "Star Spangled Banner" while cutting the boy's hair and tossing chunks behind her.The district attorney's office did not know if Gieszinger had retained an attorney. 797

WASHINGTON — U.S. health regulators posted a positive review of Pfizer's COVID-19 vaccine as they near a decision on whether to allow use of the shot. The review posted online Tuesday by the Food and Drug Administration offers the world the first detailed look at the evidence behind the shot, which was co-developed with BioNTech. The FDA review comes before a Thursday meeting where a panel of independent experts will scrutinize the data and vote on whether to recommend use of the vaccine.The vote isn't binding but the FDA usually follows the group's guidance. A U.S. decision to allow use of the vaccine is expected within days. 642

Wall Street does not like the mixed messages coming out of the White House on trade.The Dow fell 600 points, or 2.4%, on Friday afternoon. The Nasdaq plunged 3%, while the S&P 500 retreated 2.4%.The Dow closed for the day down 588 points.Stocks had been trading higher earlier Friday, but the market turned sharply lower following conflicting messages coming out of the Trump administration about trade.While White House economic adviser Larry Kudlow sounded an optimistic note about China talks on CNBC, trade adviser Peter Navarro was simultaneously warning on CNN of higher tariffs if issues aren't resolved during the 90-day negotiating period."We've gotten a hodge-podge of mixed messages from people in the same administration," said Art Hogan, chief market strategist at B. Riley FBR. "We're not sure who we're supposed to listen to."Investors also received a softer jobs report on Friday. The Labor Department said the United States?added 155,000 jobs in November, missing expectations for a gain of 200,000. But the labor news did not trigger a selloff and some traders likely figured the slowdown in hiring will reduce pressure on the Federal Reserve to raise interest rates.Worries about the negative consequences of the trade war and hopes for progress have launched Wall Street on a wild ride of late. The US-China ceasefire sent stocks soaring on Monday. But doubts about the truce helped knock the Dow nearly 800 points into the red on Tuesday. And then the Dow plunged 785 points on Thursday before staging a huge comeback."It doesn't feel like much of a ceasefire," said Ed Yardeni, president of investment advisory Yardeni Research. 1697